Insider Trading - Equels Thomas K
Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-07-16 Purchase | 2021-07-16 12:07 pm | AIM ImmunoTech Inc. | AIM | EQUELS THOMAS K. CEO | 15,625 | $1.92 | $30,000 | 225,255 (Direct) | View |
| 2021-02-24 Purchase | 2021-02-24 12:03 pm | AIM ImmunoTech Inc. | AIM | EQUELS THOMAS K. CEO | 11,062 | $2.26 | $25,000 | 209,630 (Direct) | View |
| 2020-12-17 Purchase | 2020-12-17 12:22 pm | AIM ImmunoTech Inc. | AIM | EQUELS THOMAS K. CEO | 14,535 | $1.72 | $25,000 | 198,568 (Direct) | View |
| 2020-09-03 Purchase | 2020-09-03 10:53 am | AIM ImmunoTech Inc. | AIM | EQUELS THOMAS K. CEO | 12,316 | $2.03 | $25,001 | 184,033 (Direct) | View |
| 2020-08-21 Purchase | 2020-08-21 08:08 am | AIM ImmunoTech Inc. | AIM | EQUELS THOMAS K. CEO | 10,730 | $2.33 | $25,001 | 171,717 (Direct) | View |
| 2019-06-27 Purchase | 2019-06-27 3:32 pm | HEMISPHERX BIOPHARMA INC | HEB | EQUELS THOMAS K. CEO | 2,632 | $4.37 | $11,502 | 63,041 (Direct) | View |
| 2019-06-21 Purchase(A) | 2019-06-25 12:17 pm | HEMISPHERX BIOPHARMA INC | HEB | EQUELS THOMAS K. CEO | 29,404 | $4.03 | $118,498 | 60,409 (Direct) | View |
| 2019-06-21 Purchase | 2019-06-21 11:11 am | HEMISPHERX BIOPHARMA INC | HEB | EQUELS THOMAS K. CEO | 29,404 | $4.03 | $118,498 | 1,393,611 (Direct) | View |
| 2019-03-19 Purchase | 2019-03-19 4:01 pm | HEMISPHERX BIOPHARMA INC | HEB | EQUELS THOMAS K. CEO | 13,400 | $0.1755 | $2,352 | 811,707 (Direct) | View |
| 2018-11-30 Purchase | 2018-12-03 11:32 am | HEMISPHERX BIOPHARMA INC | HEB | EQUELS THOMAS K. CEO | 20,000 | $0.19225 | $3,845 | 798,307 (Direct) | View |
| 2018-10-26 Purchase | 2018-10-29 09:14 am | HEMISPHERX BIOPHARMA INC | HEB | EQUELS THOMAS K. CEO | 3,500 | $0.203 | $711 | 775,807 (Direct) | View |
| 2018-10-25 Purchase | 2018-10-25 09:22 am | HEMISPHERX BIOPHARMA INC | HEB | EQUELS THOMAS K. CEO | 100,000 | $0.2 | $20,000 | 772,307 (Direct) | View |
| 2018-07-27 Purchase | 2018-07-27 09:31 am | HEMISPHERX BIOPHARMA INC | HEB | EQUELS THOMAS K. CEO | 34,483 | $0.29 | $10,000 | 672,306 (Direct) | View |
| 2018-07-23 Purchase | 2018-07-23 10:49 am | HEMISPHERX BIOPHARMA INC | HEB | EQUELS THOMAS K. CEO | 112,904 | $0.31 | $35,000 | 637,823 (Direct) | View |
| 2018-04-27 Purchase | 2018-04-30 06:22 am | HEMISPHERX BIOPHARMA INC | HEB | EQUELS THOMAS K. CEO | 32,000 | $0.32 | $10,240 | 524,919 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-12-13(A) Option Award | 2021-12-13 11:43 am | N/A N/A | AIM ImmunoTech Inc. | AIM | Equels Thomas K CEO | 21,552 | $1.16 | 300,789 (Direct) | View |
| 2021-12-13 Option Award | 2021-12-13 11:26 am | N/A N/A | AIM ImmunoTech Inc. | AIM | Equels Thomas K CEO | 21,552 | $1.16 | 300,789 (Direct) | View |
| 2021-12-10 Option Award | 2021-12-10 10:55 am | N/A N/A | AIM ImmunoTech Inc. | AIM | Equels Thomas K CEO | 11,811 | $1.27 | 279,237 (Direct) | View |
| 2021-11-24 Option Award | 2021-11-24 1:51 pm | N/A N/A | AIM ImmunoTech Inc. | AIM | EQUELS THOMAS K. CEO | 11,627 | $1.29 | 267,426 (Direct) | View |
| 2021-11-23 Option Award | 2021-11-23 11:08 am | N/A N/A | AIM ImmunoTech Inc. | AIM | EQUELS THOMAS K. CEO | 11,194 | $1.34 | 255,799 (Direct) | View |
| 2021-11-19 Option Award | 2021-11-19 11:28 am | N/A N/A | AIM ImmunoTech Inc. | AIM | EQUELS THOMAS K. CEO | 10,204 | $1.47 | 244,605 (Direct) | View |
| 2021-11-17 Option Award | 2021-11-17 5:27 pm | N/A N/A | AIM ImmunoTech Inc. | AIM | EQUELS THOMAS K. CEO | 9,146 | $1.64 | 234,401 (Direct) | View |
| 2021-11-11 Option Award | 2021-11-15 4:57 pm | 2022-11-11 2031-11-11 | AIM ImmunoTech Inc. | AIM | EQUELS THOMAS K. CEO | 300,000 | $0 | 300,000 (Direct) | View |
| 2020-11-11 Option Award | 2020-11-13 10:38 am | 2021-11-11 2030-11-11 | AIM ImmunoTech Inc. | AIM | EQUELS THOMAS K. CEO | 300,000 | $0 | 300,000 (Direct) | View |
| 2020-08-12 Option Award | 2020-08-14 3:32 pm | 2021-08-12 2030-08-12 | AIM ImmunoTech Inc. | AIM | EQUELS THOMAS K. CEO | 300,000 | $0 | 300,000 (Direct) | View |
| 2019-12-31 Option Award | 2020-01-02 10:47 am | N/A N/A | AIM ImmunoTech Inc. | AIM | EQUELS THOMAS K. CEO | 14,741 | $0.53 | 160,990 (Direct) | View |
| 2019-12-13 Option Award | 2019-12-16 09:25 am | N/A N/A | AIM ImmunoTech Inc. | AIM | EQUELS THOMAS K. CEO | 17,960 | $0.435 | 146,249 (Direct) | View |
| 2019-11-29 Option Award | 2019-12-02 11:48 am | N/A N/A | AIM ImmunoTech Inc. | AIM | EQUELS THOMAS K. CEO | 19,531 | $0.4 | 128,289 (Direct) | View |
| 2019-11-15 Option Award | 2019-11-18 2:30 pm | N/A N/A | AIM ImmunoTech Inc. | AIM | EQUELS THOMAS K. CEO | 16,622 | $0.47 | 108,758 (Direct) | View |
| 2019-10-31 Option Award | 2019-10-31 11:36 am | N/A N/A | AIM ImmunoTech Inc. | AIM | EQUELS THOMAS K. CEO | 15,625 | $0.5 | 92,136 (Direct) | View |
| 2019-10-15 Option Award | 2019-10-17 4:32 pm | N/A N/A | AIM ImmunoTech Inc. | AIM | EQUELS THOMAS K. CEO | 13,470 | $0.58 | 76,511 (Direct) | View |
| 2019-03-18 Conversion | 2019-06-17 1:23 pm | N/A N/A | HEMISPHERX BIOPHARMA INC | HEB | EQUELS THOMAS K. CEO | 552,500 | $0 | 1,364,207 (Direct) | View |
| 2019-02-27 Exercise | 2019-03-12 4:29 pm | 2019-02-14 2019-03-05 | HEMISPHERX BIOPHARMA INC | HEB | EQUELS THOMAS K. CEO | 65 | $1000 | 325,000 (Direct) | View |
| 2019-02-27 Exercise | 2019-03-12 4:29 pm | N/A N/A | HEMISPHERX BIOPHARMA INC | HEB | EQUELS THOMAS K. CEO | 325,065 | $0 | 325,000 (Direct) | View |
| 2019-01-28 Option Award | 2019-01-30 10:20 am | 2019-01-28 2029-01-28 | HEMISPHERX BIOPHARMA INC | HEB | EQUELS THOMAS K. CEO | 426,136 | $0 | 426,136 (Direct) | View |
| 2018-11-27 Option Award | 2018-11-29 10:34 am | N/A N/A | HEMISPHERX BIOPHARMA INC | HEB | EQUELS THOMAS K. CEO | 2,500 | $0 | 778,307 (Direct) | View |
| 2018-11-14 Option Award | 2018-11-16 11:22 am | 2018-11-14 2028-11-14 | HEMISPHERX BIOPHARMA INC | HEB | EQUELS THOMAS K. CEO | 1,000 | $0 | 1,000 (Direct) | View |
| 2018-10-17 Option Award | 2018-10-19 12:31 pm | 2018-10-17 2028-10-17 | HEMISPHERX BIOPHARMA INC | HEB | EQUELS THOMAS K. CEO | 284,091 | $0 | 284,091 (Direct) | View |
| 2018-07-18 Option Award | 2018-07-19 2:41 pm | 2018-07-18 2028-07-18 | HEMISPHERX BIOPHARMA INC | HEB | EQUELS THOMAS K. CEO | 161,290 | $0 | 161,290 (Direct) | View |
| 2018-05-16 Other | 2018-05-18 11:13 am | 2018-05-16 2028-05-16 | HEMISPHERX BIOPHARMA INC | HEB | EQUELS THOMAS K. CEO | 300,000 | $0 | 1,045,833 (Direct) | View |
| 2018-05-16 Option Award | 2018-05-18 11:13 am | 2018-05-16 2028-05-16 | HEMISPHERX BIOPHARMA INC | HEB | EQUELS THOMAS K. CEO | 250,000 | $0 | 1,045,833 (Direct) | View |
| 2018-04-12 Option Award | 2018-04-19 3:01 pm | 2018-04-12 2028-04-12 | HEMISPHERX BIOPHARMA INC | HEB | EQUELS THOMAS K. CEO | 125,000 | $0 | 125,000 (Direct) | View |